| Literature DB >> 23269415 |
E R Martins1, A Andreu, J Melo-Cristino, M Ramirez.
Abstract
At least one pilus island, PI-1 (70%), PI-2a (79%), or PI-2b (21%), was found among 898 Streptococcus agalactiae (group B streptococcus [GBS]) isolates recovered from humans, supporting the use of pilus proteins in vaccines. The stability and dominance of PI-1 and PI-2a in multiple serotypes and founder multilocus sequence types disseminated worldwide suggest it could be the PI combination present in ancestral GBS human pathogens.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23269415 PMCID: PMC3571264 DOI: 10.1128/CVI.00529-12
Source DB: PubMed Journal: Clin Vaccine Immunol ISSN: 1556-679X